Billroth II Versus Roux-en-Y for the Gastrojejunostomy in the Pancreatoduodenectomy
NCT ID: NCT01984216
Last Updated: 2016-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
64 participants
INTERVENTIONAL
2013-11-30
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic One Anastomosis Gastric Bypass
NCT02779322
Quality of Life After Billroth II or Roux-en-Y for Gastric Cancer
NCT06768164
The Advantages and Disadvantages Between Uncut Roux-en-Y Reconstruction and Billroth II Reconstruction After Laparoscopy-assisted Distal Gastrectomy for Gastric
NCT02694081
Endoscopic Stomach and Pouch Reduction in Patients With Weight Regain Following Roux-En-Y Bypass Surgery
NCT00411489
Laparoscopic Gastric Bypass Versus Laparoscopic Banded Gastric Bypass Randomized Prospective Clinical Trial
NCT02939664
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Roux-en-Y
Roux-en-Y for the gastrojejunostomy reconstruction
Roux-en-Y for the gastrojejunostomy reconstruction
Billroth II
Billroth II for the gastrojejunostomy reconstruction
Billroth II for the gastrojejunostomy reconstruction
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Roux-en-Y for the gastrojejunostomy reconstruction
Billroth II for the gastrojejunostomy reconstruction
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Given informed consent.
Exclusion Criteria
* Resection of other organs, except the superior mesenteric-portal vein.
* Previous gastric surgery.
* Preoperative gastric or duodenal obstruction.
* Previous complex abdominal surgery.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundacion Miguel Servet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Francisco Javier Herrera, MD
Role: PRINCIPAL_INVESTIGATOR
Complejo Hospitalario de Navarra
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Complejo Hospitalario de Navarra
Pamplona, Navarre, Spain
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Navarrabiomed: the biomedical research branch of Complejo Hospitalario de Navarra
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-000693-30
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
CIRUGIA-CHN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.